Last reviewed · How we verify
Butanedioic Acid (SUCCINIC ACID)
Butanedioic Acid (generic name: SUCCINIC ACID) is a Vitamin C [EPC] drug. It is currently FDA-approved for Iron deficiency anemia.
Butanedioic acid, also known as succinic acid, is a small molecule. It is being studied in clinical trials for various conditions, including ischemic stroke, hypertension, and neuromyelitis optica spectrum disorder.
At a glance
| Generic name | SUCCINIC ACID |
|---|---|
| Drug class | Vitamin C [EPC] |
| Target | Egl nine homolog 1 |
| Modality | Small molecule |
| Therapeutic area | Hematology |
| Phase | FDA-approved |
Approved indications
- Iron deficiency anemia
Common side effects
Key clinical trials
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial (PHASE3)
- Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score (PHASE4)
- RELISTOR's Effects on Opioid-Induced Constipation
- Postpartum 8-aminoquinoline Breast Milk Study (PHASE2,PHASE3)
- Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children (PHASE4)
- Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women (PHASE4)
- Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma (PHASE2)
- Venetoclax Basket Trial for High Risk Hematologic Malignancies (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Butanedioic Acid CI brief — competitive landscape report
- Butanedioic Acid updates RSS · CI watch RSS
Frequently asked questions about Butanedioic Acid
What is Butanedioic Acid?
What is Butanedioic Acid used for?
What is the generic name of Butanedioic Acid?
What drug class is Butanedioic Acid in?
What development phase is Butanedioic Acid in?
What does Butanedioic Acid target?
Related
- Drug class: All Vitamin C [EPC] drugs
- Target: All drugs targeting Egl nine homolog 1
- Therapeutic area: All drugs in Hematology
- Indication: Drugs for Iron deficiency anemia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing